DNAJB12P1

Across TCGA pan-cancer cohorts, DNAJB12P1 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated DNAJB12P1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher DNAJB12P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DNAJB12P1 expression acts as an unfavorable survival marker, although some lineages such as LUAD and HNSC show a favorable association.

ACC, UVM, and STAD are the cancer types where DNAJB12P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	II,III,IV	0.171	0.584	<.001	79	view →
UVM	DFS	Quartile	II,III,IV	0.301	0.631	<.001	75	view →
STAD	OS	Median	II,III,IV	0.391	0.729	<.001	63	view →
COAD	OS	Tertile	II,III,IV	0.437	0.654	.002	56	view →
LUSC	DFS	Median	All	0.280	0.498	<.001	39	view →
LUAD	DFS	Median	IV	0.662	0.327	.006	34	view →
LGG	OS	Median	All	0.745	0.864	<.001	27	view →
CESC	DFS	Quartile	III,IV	0.188	0.530	.009	26	view →
CHOL	DFS	Median	II,III,IV	0.120	0.535	.034	18	view →
HNSC	DFS	Tertile	II,III,IV	0.438	0.322	.017	13	view →
KIRC	DFS	Tertile	IV	0.344	0.641	.007	12	view →
BRCA	DFS	Median	III,IV	0.916	0.836	.023	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

DNAJB12P1–ACC (DFS)

Open the ACC breakdown →